estradiol 0.0375 MG/Day Twice Weekly Transdermal System

RxCUI
241946
RxNorm name
estradiol 0.0375 MG/Day Twice Weekly Transdermal System
Display name
estradiol 0.0375 MG/Day Twice Weekly Transdermal System
Full name
estradiol 0.0375 MG/Day Twice Weekly Transdermal System
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:28

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 14 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
EstradiolESTRADIOLA-S Medication Solutions13f9c41b-417c-45e4-9a59-baf774fca78d2025-07-24Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 241946
EstradiolESTRADIOLMylan Pharmaceuticals Inc.f4efb0bf-b96f-4e20-a0f2-0806ab92b2d42025-06-23Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 241946
EstradiolESTRADIOLMylan Pharmaceuticals Inc.d28bec8f-762e-4f05-a20d-96a42970d6a72025-06-17Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 241946
DOTTIESTRADIOLBryant Ranch Prepackf419192a-eb95-4087-9fe0-0eea639ef51b2024-08-12Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 241946
EstradiolESTRADIOLAmneal Pharmaceuticals NY LLCd4259bb8-91f8-4587-8ceb-35d44145aec02024-05-15Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 241946
LYLLANAESTRADIOLAmneal Pharmaceuticals LLC09c472c6-a38a-4a3d-b048-6fefd52e2ad32024-05-15Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 241946
EstradiolESTRADIOLAmneal Pharmaceuticals NY LLC0500ee9b-bf4a-4432-9afe-20a7d60a6fe52024-05-14Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 241946
DOTTIESTRADIOLAmneal Pharmaceuticals LLC53016d30-6b5f-49da-ac16-85ef415a58052024-05-14Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 241946
EstradiolESTRADIOLNoven Therapeutics, LLCbf185599-2138-4083-9c52-2b95dce09ae02024-04-05Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 241946
EstradiolESTRADIOLZydus Pharmaceuticals USA Inc.839fe7ae-6835-4d6a-b6b1-ca7f062caa4f2024-03-15Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 241946
EstradiolESTRADIOLSandoz Incc4da6de7-9ab1-4fcf-88f3-fe785019e6e72024-02-29Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 241946
MinivelleESTRADIOLNoven Therapeutics, LLC6c5c47ab-28ee-11e1-bfc2-0800200c9a662024-02-22Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 241946
Vivelle-DotESTRADIOLSandoz Inc5ccb77f9-d47b-4381-ad5c-5b92524e1c4a2023-11-17Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 241946
EstradiolESTRADIOLZydus Lifesciences Limitedb79fd5ea-962f-491c-b670-40efe42ccf792022-12-07Exact identifier
rxcui: 241946

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
f419192a-eb95-4087-9fe0-0eea639ef51bestradiol 37.5 MCG/Day Twice Weekly Transdermal PatchSY102These highlights do not include all the information needed to use DOTTI safely and effectively. See full prescribing information for DOTTI. DOTTI ® (estradiol transdermal system) Initial U.S. Approval: 199620240812
f419192a-eb95-4087-9fe0-0eea639ef51b84 HR estradiol 0.00156 MG/HR Transdermal SystemSCD102These highlights do not include all the information needed to use DOTTI safely and effectively. See full prescribing information for DOTTI. DOTTI ® (estradiol transdermal system) Initial U.S. Approval: 199620240812
f419192a-eb95-4087-9fe0-0eea639ef51bestradiol 0.0375 MG/Day Twice Weekly Transdermal SystemPSN102These highlights do not include all the information needed to use DOTTI safely and effectively. See full prescribing information for DOTTI. DOTTI ® (estradiol transdermal system) Initial U.S. Approval: 199620240812
f419192a-eb95-4087-9fe0-0eea639ef51bestradiol 0.00156 MG/HR 84 HR Transdermal PatchSY102These highlights do not include all the information needed to use DOTTI safely and effectively. See full prescribing information for DOTTI. DOTTI ® (estradiol transdermal system) Initial U.S. Approval: 199620240812
f419192a-eb95-4087-9fe0-0eea639ef51bestradiol 0.0375 MG/Day Twice Weekly Transdermal SystemSY102These highlights do not include all the information needed to use DOTTI safely and effectively. See full prescribing information for DOTTI. DOTTI ® (estradiol transdermal system) Initial U.S. Approval: 199620240812
6c5c47ab-28ee-11e1-bfc2-0800200c9a66estradiol 37.5 MCG/Day Twice Weekly Transdermal PatchSY19These highlights do not include all the information needed to use MINIVELLE safely and effectively. See full prescribing information for MINIVELLE. MINIVELLE ® (estradiol transdermal system) Initial U.S. Approval: 197520240222
6c5c47ab-28ee-11e1-bfc2-0800200c9a6684 HR estradiol 0.00156 MG/HR Transdermal SystemSCD19These highlights do not include all the information needed to use MINIVELLE safely and effectively. See full prescribing information for MINIVELLE. MINIVELLE ® (estradiol transdermal system) Initial U.S. Approval: 197520240222
6c5c47ab-28ee-11e1-bfc2-0800200c9a66estradiol 0.00156 MG/HR 84 HR Transdermal PatchSY19These highlights do not include all the information needed to use MINIVELLE safely and effectively. See full prescribing information for MINIVELLE. MINIVELLE ® (estradiol transdermal system) Initial U.S. Approval: 197520240222
6c5c47ab-28ee-11e1-bfc2-0800200c9a66estradiol 0.0375 MG/Day Twice Weekly Transdermal SystemPSN19These highlights do not include all the information needed to use MINIVELLE safely and effectively. See full prescribing information for MINIVELLE. MINIVELLE ® (estradiol transdermal system) Initial U.S. Approval: 197520240222
6c5c47ab-28ee-11e1-bfc2-0800200c9a66estradiol 0.0375 MG/Day Twice Weekly Transdermal SystemSY19These highlights do not include all the information needed to use MINIVELLE safely and effectively. See full prescribing information for MINIVELLE. MINIVELLE ® (estradiol transdermal system) Initial U.S. Approval: 197520240222
0500ee9b-bf4a-4432-9afe-20a7d60a6fe5estradiol 0.0375 MG/Day Twice Weekly Transdermal SystemSY17These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM. ESTRADIOL transdermal system Initial U.S. Approval: 199620240514
0500ee9b-bf4a-4432-9afe-20a7d60a6fe5estradiol 37.5 MCG/Day Twice Weekly Transdermal PatchSY17These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM. ESTRADIOL transdermal system Initial U.S. Approval: 199620240514
0500ee9b-bf4a-4432-9afe-20a7d60a6fe5estradiol 0.00156 MG/HR 84 HR Transdermal PatchSY17These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM. ESTRADIOL transdermal system Initial U.S. Approval: 199620240514
0500ee9b-bf4a-4432-9afe-20a7d60a6fe5estradiol 0.0375 MG/Day Twice Weekly Transdermal SystemPSN17These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM. ESTRADIOL transdermal system Initial U.S. Approval: 199620240514
0500ee9b-bf4a-4432-9afe-20a7d60a6fe584 HR estradiol 0.00156 MG/HR Transdermal SystemSCD17These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM. ESTRADIOL transdermal system Initial U.S. Approval: 199620240514
5ccb77f9-d47b-4381-ad5c-5b92524e1c4aestradiol 0.0375 MG/Day Twice Weekly Transdermal SystemSY17These highlights do not include all the information needed to use VIVELLE-DOT safely and effectively. See full prescribing information for VIVELLE-DOT. VIVELLE-DOT ® (estradiol transdermal system) Initial U.S. Approval: 199620231117
5ccb77f9-d47b-4381-ad5c-5b92524e1c4a84 HR estradiol 0.00156 MG/HR Transdermal SystemSCD17These highlights do not include all the information needed to use VIVELLE-DOT safely and effectively. See full prescribing information for VIVELLE-DOT. VIVELLE-DOT ® (estradiol transdermal system) Initial U.S. Approval: 199620231117
5ccb77f9-d47b-4381-ad5c-5b92524e1c4aestradiol 37.5 MCG/Day Twice Weekly Transdermal PatchSY17These highlights do not include all the information needed to use VIVELLE-DOT safely and effectively. See full prescribing information for VIVELLE-DOT. VIVELLE-DOT ® (estradiol transdermal system) Initial U.S. Approval: 199620231117
5ccb77f9-d47b-4381-ad5c-5b92524e1c4aestradiol 0.0375 MG/Day Twice Weekly Transdermal SystemPSN17These highlights do not include all the information needed to use VIVELLE-DOT safely and effectively. See full prescribing information for VIVELLE-DOT. VIVELLE-DOT ® (estradiol transdermal system) Initial U.S. Approval: 199620231117
5ccb77f9-d47b-4381-ad5c-5b92524e1c4aestradiol 0.00156 MG/HR 84 HR Transdermal PatchSY17These highlights do not include all the information needed to use VIVELLE-DOT safely and effectively. See full prescribing information for VIVELLE-DOT. VIVELLE-DOT ® (estradiol transdermal system) Initial U.S. Approval: 199620231117
09c472c6-a38a-4a3d-b048-6fefd52e2ad384 HR estradiol 0.00156 MG/HR Transdermal SystemSCD15These highlights do not include all the information needed to use LYLLANA safely and effectively. See full prescribing information for LYLLANA. LYLLANA ® (estradiol transdermal system) Initial U.S. Approval: 197520240515
09c472c6-a38a-4a3d-b048-6fefd52e2ad3estradiol 37.5 MCG/Day Twice Weekly Transdermal PatchSY15These highlights do not include all the information needed to use LYLLANA safely and effectively. See full prescribing information for LYLLANA. LYLLANA ® (estradiol transdermal system) Initial U.S. Approval: 197520240515
09c472c6-a38a-4a3d-b048-6fefd52e2ad3estradiol 0.00156 MG/HR 84 HR Transdermal PatchSY15These highlights do not include all the information needed to use LYLLANA safely and effectively. See full prescribing information for LYLLANA. LYLLANA ® (estradiol transdermal system) Initial U.S. Approval: 197520240515
09c472c6-a38a-4a3d-b048-6fefd52e2ad3estradiol 0.0375 MG/Day Twice Weekly Transdermal SystemSY15These highlights do not include all the information needed to use LYLLANA safely and effectively. See full prescribing information for LYLLANA. LYLLANA ® (estradiol transdermal system) Initial U.S. Approval: 197520240515
09c472c6-a38a-4a3d-b048-6fefd52e2ad3estradiol 0.0375 MG/Day Twice Weekly Transdermal SystemPSN15These highlights do not include all the information needed to use LYLLANA safely and effectively. See full prescribing information for LYLLANA. LYLLANA ® (estradiol transdermal system) Initial U.S. Approval: 197520240515
d28bec8f-762e-4f05-a20d-96a42970d6a784 HR estradiol 0.00156 MG/HR Transdermal SystemSCD14These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY) safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY). ESTRADIOL transdermal system (twice-weekly) Initial U.S. Approval: 199620250617
d28bec8f-762e-4f05-a20d-96a42970d6a7estradiol 0.0375 MG/Day Twice Weekly Transdermal SystemPSN14These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY) safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY). ESTRADIOL transdermal system (twice-weekly) Initial U.S. Approval: 199620250617
d28bec8f-762e-4f05-a20d-96a42970d6a7estradiol 0.0375 MG/Day Twice Weekly Transdermal SystemSY14These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY) safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY). ESTRADIOL transdermal system (twice-weekly) Initial U.S. Approval: 199620250617
d28bec8f-762e-4f05-a20d-96a42970d6a7estradiol 37.5 MCG/Day Twice Weekly Transdermal PatchSY14These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY) safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY). ESTRADIOL transdermal system (twice-weekly) Initial U.S. Approval: 199620250617
d28bec8f-762e-4f05-a20d-96a42970d6a7estradiol 0.00156 MG/HR 84 HR Transdermal PatchSY14These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY) safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY). ESTRADIOL transdermal system (twice-weekly) Initial U.S. Approval: 199620250617
d4259bb8-91f8-4587-8ceb-35d44145aec0estradiol 0.00156 MG/HR 84 HR Transdermal PatchSY11These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM. ESTRADIOL transdermal system Initial U.S. Approval: 197520240515
d4259bb8-91f8-4587-8ceb-35d44145aec084 HR estradiol 0.00156 MG/HR Transdermal SystemSCD11These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM. ESTRADIOL transdermal system Initial U.S. Approval: 197520240515
d4259bb8-91f8-4587-8ceb-35d44145aec0estradiol 0.0375 MG/Day Twice Weekly Transdermal SystemPSN11These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM. ESTRADIOL transdermal system Initial U.S. Approval: 197520240515
d4259bb8-91f8-4587-8ceb-35d44145aec0estradiol 37.5 MCG/Day Twice Weekly Transdermal PatchSY11These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM. ESTRADIOL transdermal system Initial U.S. Approval: 197520240515
d4259bb8-91f8-4587-8ceb-35d44145aec0estradiol 0.0375 MG/Day Twice Weekly Transdermal SystemSY11These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM. ESTRADIOL transdermal system Initial U.S. Approval: 197520240515
c4da6de7-9ab1-4fcf-88f3-fe785019e6e7estradiol 37.5 MCG/Day Twice Weekly Transdermal PatchSY11These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM. ESTRADIOL TRANSDERMAL SYSTEM Initial U.S. Approval: 199620240229
c4da6de7-9ab1-4fcf-88f3-fe785019e6e7estradiol 0.0375 MG/Day Twice Weekly Transdermal SystemSY11These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM. ESTRADIOL TRANSDERMAL SYSTEM Initial U.S. Approval: 199620240229
c4da6de7-9ab1-4fcf-88f3-fe785019e6e7estradiol 0.00156 MG/HR 84 HR Transdermal PatchSY11These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM. ESTRADIOL TRANSDERMAL SYSTEM Initial U.S. Approval: 199620240229
c4da6de7-9ab1-4fcf-88f3-fe785019e6e784 HR estradiol 0.00156 MG/HR Transdermal SystemSCD11These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM. ESTRADIOL TRANSDERMAL SYSTEM Initial U.S. Approval: 199620240229
c4da6de7-9ab1-4fcf-88f3-fe785019e6e7estradiol 0.0375 MG/Day Twice Weekly Transdermal SystemPSN11These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM. ESTRADIOL TRANSDERMAL SYSTEM Initial U.S. Approval: 199620240229
53016d30-6b5f-49da-ac16-85ef415a580584 HR estradiol 0.00156 MG/HR Transdermal SystemSCD10These highlights do not include all the information needed to use DOTTI safely and effectively. See full prescribing information for DOTTI. DOTTI ® (estradiol transdermal system) Initial U.S. Approval: 199620240514
53016d30-6b5f-49da-ac16-85ef415a5805estradiol 0.00156 MG/HR 84 HR Transdermal PatchSY10These highlights do not include all the information needed to use DOTTI safely and effectively. See full prescribing information for DOTTI. DOTTI ® (estradiol transdermal system) Initial U.S. Approval: 199620240514
53016d30-6b5f-49da-ac16-85ef415a5805estradiol 37.5 MCG/Day Twice Weekly Transdermal PatchSY10These highlights do not include all the information needed to use DOTTI safely and effectively. See full prescribing information for DOTTI. DOTTI ® (estradiol transdermal system) Initial U.S. Approval: 199620240514
53016d30-6b5f-49da-ac16-85ef415a5805estradiol 0.0375 MG/Day Twice Weekly Transdermal SystemSY10These highlights do not include all the information needed to use DOTTI safely and effectively. See full prescribing information for DOTTI. DOTTI ® (estradiol transdermal system) Initial U.S. Approval: 199620240514
53016d30-6b5f-49da-ac16-85ef415a5805estradiol 0.0375 MG/Day Twice Weekly Transdermal SystemPSN10These highlights do not include all the information needed to use DOTTI safely and effectively. See full prescribing information for DOTTI. DOTTI ® (estradiol transdermal system) Initial U.S. Approval: 199620240514
f4efb0bf-b96f-4e20-a0f2-0806ab92b2d484 HR estradiol 0.00156 MG/HR Transdermal SystemSCD7These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY) safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY). ESTRADIOL transdermal system (twice-weekly) Initial U.S. Approval: 197520250623
f4efb0bf-b96f-4e20-a0f2-0806ab92b2d4estradiol 0.0375 MG/Day Twice Weekly Transdermal SystemSY7These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY) safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY). ESTRADIOL transdermal system (twice-weekly) Initial U.S. Approval: 197520250623
f4efb0bf-b96f-4e20-a0f2-0806ab92b2d4estradiol 37.5 MCG/Day Twice Weekly Transdermal PatchSY7These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY) safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY). ESTRADIOL transdermal system (twice-weekly) Initial U.S. Approval: 197520250623
f4efb0bf-b96f-4e20-a0f2-0806ab92b2d4estradiol 0.0375 MG/Day Twice Weekly Transdermal SystemPSN7These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY) safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY). ESTRADIOL transdermal system (twice-weekly) Initial U.S. Approval: 197520250623
f4efb0bf-b96f-4e20-a0f2-0806ab92b2d4estradiol 0.00156 MG/HR 84 HR Transdermal PatchSY7These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY) safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY). ESTRADIOL transdermal system (twice-weekly) Initial U.S. Approval: 197520250623
bf185599-2138-4083-9c52-2b95dce09ae0estradiol 0.0375 MG/Day Twice Weekly Transdermal SystemSY6These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM ESTRADIOL TRANSDERMAL SYSTEM Initial U.S. Approval: 197520240405
bf185599-2138-4083-9c52-2b95dce09ae0estradiol 0.0375 MG/Day Twice Weekly Transdermal SystemPSN6These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM ESTRADIOL TRANSDERMAL SYSTEM Initial U.S. Approval: 197520240405
bf185599-2138-4083-9c52-2b95dce09ae0estradiol 37.5 MCG/Day Twice Weekly Transdermal PatchSY6These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM ESTRADIOL TRANSDERMAL SYSTEM Initial U.S. Approval: 197520240405
bf185599-2138-4083-9c52-2b95dce09ae084 HR estradiol 0.00156 MG/HR Transdermal SystemSCD6These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM ESTRADIOL TRANSDERMAL SYSTEM Initial U.S. Approval: 197520240405
bf185599-2138-4083-9c52-2b95dce09ae0estradiol 0.00156 MG/HR 84 HR Transdermal PatchSY6These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM ESTRADIOL TRANSDERMAL SYSTEM Initial U.S. Approval: 197520240405
839fe7ae-6835-4d6a-b6b1-ca7f062caa4festradiol 0.00156 MG/HR 84 HR Transdermal PatchSY4These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY) safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY). ESTRADIOL transdermal system, USP (TWICE-WEEKLY) Initial U.S. Approval: 199620240315
839fe7ae-6835-4d6a-b6b1-ca7f062caa4f84 HR estradiol 0.00156 MG/HR Transdermal SystemSCD4These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY) safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY). ESTRADIOL transdermal system, USP (TWICE-WEEKLY) Initial U.S. Approval: 199620240315
839fe7ae-6835-4d6a-b6b1-ca7f062caa4festradiol 0.0375 MG/Day Twice Weekly Transdermal SystemSY4These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY) safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY). ESTRADIOL transdermal system, USP (TWICE-WEEKLY) Initial U.S. Approval: 199620240315
839fe7ae-6835-4d6a-b6b1-ca7f062caa4festradiol 37.5 MCG/Day Twice Weekly Transdermal PatchSY4These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY) safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY). ESTRADIOL transdermal system, USP (TWICE-WEEKLY) Initial U.S. Approval: 199620240315
839fe7ae-6835-4d6a-b6b1-ca7f062caa4festradiol 0.0375 MG/Day Twice Weekly Transdermal SystemPSN4These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY) safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY). ESTRADIOL transdermal system, USP (TWICE-WEEKLY) Initial U.S. Approval: 199620240315
13f9c41b-417c-45e4-9a59-baf774fca78d84 HR estradiol 0.00156 MG/HR Transdermal SystemSCD1These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM ESTRADIOL TRANSDERMAL SYSTEM Initial U.S. Approval: 197520250724
13f9c41b-417c-45e4-9a59-baf774fca78destradiol 37.5 MCG/Day Twice Weekly Transdermal PatchSY1These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM ESTRADIOL TRANSDERMAL SYSTEM Initial U.S. Approval: 197520250724
13f9c41b-417c-45e4-9a59-baf774fca78destradiol 0.00156 MG/HR 84 HR Transdermal PatchSY1These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM ESTRADIOL TRANSDERMAL SYSTEM Initial U.S. Approval: 197520250724
13f9c41b-417c-45e4-9a59-baf774fca78destradiol 0.0375 MG/Day Twice Weekly Transdermal SystemPSN1These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM ESTRADIOL TRANSDERMAL SYSTEM Initial U.S. Approval: 197520250724
13f9c41b-417c-45e4-9a59-baf774fca78destradiol 0.0375 MG/Day Twice Weekly Transdermal SystemSY1These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM ESTRADIOL TRANSDERMAL SYSTEM Initial U.S. Approval: 197520250724
b79fd5ea-962f-491c-b670-40efe42ccf79estradiol 0.0375 MG/Day Twice Weekly Transdermal SystemSY1ESTRADIOL transdermal system, USP (TWICE-WEEKLY)20221207
b79fd5ea-962f-491c-b670-40efe42ccf79estradiol 37.5 MCG/Day Twice Weekly Transdermal PatchSY1ESTRADIOL transdermal system, USP (TWICE-WEEKLY)20221207
b79fd5ea-962f-491c-b670-40efe42ccf79estradiol 0.0375 MG/Day Twice Weekly Transdermal SystemPSN1ESTRADIOL transdermal system, USP (TWICE-WEEKLY)20221207
b79fd5ea-962f-491c-b670-40efe42ccf79estradiol 0.00156 MG/HR 84 HR Transdermal PatchSY1ESTRADIOL transdermal system, USP (TWICE-WEEKLY)20221207
b79fd5ea-962f-491c-b670-40efe42ccf7984 HR estradiol 0.00156 MG/HR Transdermal SystemSCD1ESTRADIOL transdermal system, USP (TWICE-WEEKLY)20221207
03ab0226-b494-4607-8e8b-7381082fa780estradiol 0.00156 MG/HR 84 HR Transdermal PatchSY1Vivelle-Dot20120217
03ab0226-b494-4607-8e8b-7381082fa78084 HR estradiol 0.00156 MG/HR Transdermal SystemSCD1Vivelle-Dot20120217
03ab0226-b494-4607-8e8b-7381082fa780estradiol 0.0375 MG/Day Twice Weekly Transdermal SystemPSN1Vivelle-Dot20120217
03ab0226-b494-4607-8e8b-7381082fa780estradiol 0.0375 MG/Day Twice Weekly Transdermal SystemSY1Vivelle-Dot20120217
03ab0226-b494-4607-8e8b-7381082fa780estradiol 37.5 MCG/Day Twice Weekly Transdermal PatchSY1Vivelle-Dot20120217